

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | tonic smooth muscle contraction (GO:0014820) | 7.48627109 |
| 2 | regulation of hypersensitivity (GO:0002883) | 6.82354753 |
| 3 | positive regulation of mast cell degranulation (GO:0043306) | 6.57850786 |
| 4 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 6.57850786 |
| 5 | neutrophil activation involved in immune response (GO:0002283) | 6.03443782 |
| 6 | positive regulation of mast cell activation (GO:0033005) | 5.91493128 |
| 7 | extracellular matrix assembly (GO:0085029) | 5.89335985 |
| 8 | spindle assembly involved in mitosis (GO:0090307) | 5.68038116 |
| 9 | protein autoprocessing (GO:0016540) | 5.64141019 |
| 10 | negative regulation of glycoprotein biosynthetic process (GO:0010561) | 5.63329722 |
| 11 | lung vasculature development (GO:0060426) | 5.61697811 |
| 12 | xenobiotic catabolic process (GO:0042178) | 5.44664532 |
| 13 | negative regulation of heart growth (GO:0061117) | 5.43622073 |
| 14 | negative regulation of cardiac muscle tissue growth (GO:0055022) | 5.43622073 |
| 15 | positive regulation of inflammatory response to antigenic stimulus (GO:0002863) | 5.29848997 |
| 16 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 5.24450105 |
| 17 | immunoglobulin mediated immune response (GO:0016064) | 5.11382185 |
| 18 | negative regulation of cardiac muscle hypertrophy (GO:0010614) | 5.10894680 |
| 19 | galactose catabolic process (GO:0019388) | 5.02977114 |
| 20 | cellular response to osmotic stress (GO:0071470) | 5.02565566 |
| 21 | positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725) | 4.94334141 |
| 22 | smooth muscle contraction (GO:0006939) | 4.89402440 |
| 23 | regulation of acute inflammatory response to antigenic stimulus (GO:0002864) | 4.80466759 |
| 24 | lung lobe morphogenesis (GO:0060463) | 4.76476294 |
| 25 | vascular smooth muscle contraction (GO:0014829) | 4.71549226 |
| 26 | respiratory tube development (GO:0030323) | 4.63522280 |
| 27 | positive regulation of leukocyte degranulation (GO:0043302) | 4.61861673 |
| 28 | negative regulation of muscle hypertrophy (GO:0014741) | 4.49481440 |
| 29 | relaxation of smooth muscle (GO:0044557) | 4.45407767 |
| 30 | regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645) | 4.44649639 |
| 31 | establishment of apical/basal cell polarity (GO:0035089) | 4.43785810 |
| 32 | regulation of mast cell degranulation (GO:0043304) | 4.42013667 |
| 33 | polarized epithelial cell differentiation (GO:0030859) | 4.40213810 |
| 34 | regulation of triglyceride catabolic process (GO:0010896) | 4.33747981 |
| 35 | sphingosine metabolic process (GO:0006670) | 4.26251991 |
| 36 | mature B cell differentiation involved in immune response (GO:0002313) | 4.24762104 |
| 37 | microtubule cytoskeleton organization involved in mitosis (GO:1902850) | 4.20022589 |
| 38 | negative regulation of glycoprotein metabolic process (GO:1903019) | 4.15200808 |
| 39 | platelet aggregation (GO:0070527) | 4.13840641 |
| 40 | protein localization to cell surface (GO:0034394) | 4.11812800 |
| 41 | regulation of plasminogen activation (GO:0010755) | 4.10081847 |
| 42 | lung morphogenesis (GO:0060425) | 4.08383939 |
| 43 | cGMP-mediated signaling (GO:0019934) | 4.05324487 |
| 44 | negative regulation of catenin import into nucleus (GO:0035414) | 4.03721502 |
| 45 | antigen processing and presentation via MHC class Ib (GO:0002475) | 4.03398781 |
| 46 | regulation of mast cell activation involved in immune response (GO:0033006) | 4.01591838 |
| 47 | epithelial cell differentiation involved in prostate gland development (GO:0060742) | 4.00725610 |
| 48 | citrulline biosynthetic process (GO:0019240) | 3.98973024 |
| 49 | regulation of cholesterol esterification (GO:0010872) | 3.98458815 |
| 50 | regulation of protein glycosylation (GO:0060049) | 3.97259708 |
| 51 | mRNA transcription from RNA polymerase II promoter (GO:0042789) | 3.95987903 |
| 52 | B cell mediated immunity (GO:0019724) | 3.95289059 |
| 53 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.94126697 |
| 54 | planar cell polarity pathway involved in neural tube closure (GO:0090179) | 3.90118320 |
| 55 | outflow tract septum morphogenesis (GO:0003148) | 3.89404663 |
| 56 | mesenchymal cell differentiation involved in kidney development (GO:0072161) | 3.86539675 |
| 57 | mesenchymal cell differentiation involved in renal system development (GO:2001012) | 3.86539675 |
| 58 | diol metabolic process (GO:0034311) | 3.85542178 |
| 59 | phospholipid efflux (GO:0033700) | 3.84566221 |
| 60 | regulation of mast cell activation (GO:0033003) | 3.80826772 |
| 61 | response to nitrosative stress (GO:0051409) | 3.79816248 |
| 62 | establishment of monopolar cell polarity (GO:0061162) | 3.78958613 |
| 63 | establishment or maintenance of monopolar cell polarity (GO:0061339) | 3.78958613 |
| 64 | leukotriene biosynthetic process (GO:0019370) | 3.78091940 |
| 65 | vasoconstriction (GO:0042310) | 3.74159234 |
| 66 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.61238497 |
| 67 | midgut development (GO:0007494) | 3.58759591 |
| 68 | respiratory electron transport chain (GO:0022904) | 3.56481811 |
| 69 | regulation of skeletal muscle contraction (GO:0014819) | 3.54627582 |
| 70 | regulation of establishment of planar polarity involved in neural tube closure (GO:0090178) | 3.54209078 |
| 71 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.52373083 |
| 72 | intestinal cholesterol absorption (GO:0030299) | 3.51995144 |
| 73 | response to peptidoglycan (GO:0032494) | 3.49707698 |
| 74 | electron transport chain (GO:0022900) | 3.47559431 |
| 75 | purine deoxyribonucleotide catabolic process (GO:0009155) | 3.46346022 |
| 76 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.46142734 |
| 77 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.46142734 |
| 78 | ATP synthesis coupled proton transport (GO:0015986) | 3.43056754 |
| 79 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 3.43056754 |
| 80 | mRNA transcription (GO:0009299) | 3.42722054 |
| 81 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.42515603 |
| 82 | endocardial cushion morphogenesis (GO:0003203) | 3.41924723 |
| 83 | regulation of inflammatory response to antigenic stimulus (GO:0002861) | 3.41595008 |
| 84 | positive regulation of regulated secretory pathway (GO:1903307) | 3.41060122 |
| 85 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 3.41042728 |
| 86 | cell differentiation involved in metanephros development (GO:0072202) | 3.40867346 |
| 87 | response to muscle activity (GO:0014850) | 3.40849100 |
| 88 | regulation of transcription from RNA polymerase II promoter involved in heart development (GO:190121 | 3.35607095 |
| 89 | regulation of cell-cell adhesion mediated by cadherin (GO:2000047) | 3.35050052 |
| 90 | plasma lipoprotein particle assembly (GO:0034377) | 3.35030441 |
| 91 | detection of molecule of bacterial origin (GO:0032490) | 3.34660179 |
| 92 | regulation of cardiac muscle cell differentiation (GO:2000725) | 3.31792907 |
| 93 | acrosome reaction (GO:0007340) | 3.31294999 |
| 94 | regulation of leukocyte degranulation (GO:0043300) | 3.31196050 |
| 95 | cholesterol efflux (GO:0033344) | 3.29832279 |
| 96 | negative regulation of cardiac muscle tissue development (GO:0055026) | 3.28390533 |
| 97 | embryonic foregut morphogenesis (GO:0048617) | 3.27058318 |
| 98 | reverse cholesterol transport (GO:0043691) | 3.22786618 |
| 99 | high-density lipoprotein particle remodeling (GO:0034375) | 3.21172749 |
| 100 | regulation of smooth muscle contraction (GO:0006940) | 3.20627312 |
| 101 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 3.20569214 |
| 102 | sphingoid metabolic process (GO:0046519) | 3.20167655 |
| 103 | skeletal muscle contraction (GO:0003009) | 3.20102838 |
| 104 | hyperosmotic salinity response (GO:0042538) | 3.19313847 |
| 105 | detection of external biotic stimulus (GO:0098581) | 3.18881503 |
| 106 | plasma lipoprotein particle remodeling (GO:0034369) | 3.16757015 |
| 107 | protein-lipid complex remodeling (GO:0034368) | 3.16757015 |
| 108 | macromolecular complex remodeling (GO:0034367) | 3.16757015 |
| 109 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 3.16726335 |
| 110 | neutrophil activation (GO:0042119) | 3.14751690 |
| 111 | actin-myosin filament sliding (GO:0033275) | 3.14555442 |
| 112 | muscle filament sliding (GO:0030049) | 3.14555442 |
| 113 | protein-lipid complex assembly (GO:0065005) | 3.14486796 |
| 114 | detection of bacterium (GO:0016045) | 3.14472462 |
| 115 | negative regulation of sterol transport (GO:0032372) | 3.14316138 |
| 116 | negative regulation of cholesterol transport (GO:0032375) | 3.14316138 |
| 117 | Golgi transport vesicle coating (GO:0048200) | 3.13058440 |
| 118 | COPI coating of Golgi vesicle (GO:0048205) | 3.13058440 |
| 119 | pinocytosis (GO:0006907) | 3.11539878 |
| 120 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.09108293 |
| 121 | hepatocyte apoptotic process (GO:0097284) | 3.07391455 |
| 122 | mesenchyme morphogenesis (GO:0072132) | 3.06707828 |
| 123 | renal absorption (GO:0070293) | 3.06033383 |
| 124 | mature B cell differentiation (GO:0002335) | 3.05380582 |
| 125 | mast cell activation (GO:0045576) | 3.04951031 |
| 126 | gonadal mesoderm development (GO:0007506) | 3.04906113 |
| 127 | endocardial cushion development (GO:0003197) | 3.04773441 |
| 128 | cellular response to interferon-gamma (GO:0071346) | 3.04646080 |
| 129 | lung-associated mesenchyme development (GO:0060484) | 3.04401497 |
| 130 | regulation of cardiac muscle tissue growth (GO:0055021) | 3.03846109 |
| 131 | T cell costimulation (GO:0031295) | 3.03454945 |
| 132 | primary alcohol catabolic process (GO:0034310) | 3.03058647 |
| 133 | leukotriene metabolic process (GO:0006691) | 3.02475519 |
| 134 | regulation of cardiac muscle hypertrophy (GO:0010611) | 3.01742111 |
| 135 | establishment or maintenance of epithelial cell apical/basal polarity (GO:0045197) | 3.00848285 |
| 136 | ectodermal placode formation (GO:0060788) | 2.99652593 |
| 137 | lymphocyte costimulation (GO:0031294) | 2.99158053 |
| 138 | metanephric tubule development (GO:0072170) | 2.98772869 |
| 139 | metanephric nephron tubule development (GO:0072234) | 2.98772869 |
| 140 | detection of other organism (GO:0098543) | 2.98393544 |
| 141 | stress fiber assembly (GO:0043149) | 2.98210198 |
| 142 | lipoxygenase pathway (GO:0019372) | 2.97655567 |
| 143 | establishment of planar polarity (GO:0001736) | 2.97451817 |
| 144 | establishment of tissue polarity (GO:0007164) | 2.97451817 |
| 145 | cardiac muscle cell development (GO:0055013) | 2.96737220 |
| 146 | epithelial cell-cell adhesion (GO:0090136) | 2.95770377 |
| 147 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 2.93600625 |
| 148 | oxygen transport (GO:0015671) | 2.93491043 |
| 149 | flavonoid metabolic process (GO:0009812) | 2.91768245 |
| 150 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 2.90563194 |
| 151 | viral transcription (GO:0019083) | 2.89266573 |
| 152 | endothelial cell morphogenesis (GO:0001886) | 2.88709883 |
| 153 | response to xenobiotic stimulus (GO:0009410) | 2.88439697 |
| 154 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 2.87943101 |
| 155 | regulation of muscle hypertrophy (GO:0014743) | 2.86742857 |
| 156 | homotypic cell-cell adhesion (GO:0034109) | 2.86117893 |
| 157 | muscle contraction (GO:0006936) | 2.84773528 |
| 158 | tooth mineralization (GO:0034505) | 2.81306941 |
| 159 | fibroblast migration (GO:0010761) | 2.81124292 |
| 160 | glandular epithelial cell differentiation (GO:0002067) | 2.80937100 |
| 161 | sphingolipid biosynthetic process (GO:0030148) | 2.79232630 |
| 162 | detection of biotic stimulus (GO:0009595) | 2.78571449 |
| 163 | relaxation of muscle (GO:0090075) | 2.77239046 |
| 164 | myeloid cell activation involved in immune response (GO:0002275) | 2.77082021 |
| 165 | mesodermal cell differentiation (GO:0048333) | 2.75582742 |
| 166 | positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081 | 2.75401876 |
| 167 | G-protein coupled receptor signaling pathway coupled to cGMP nucleotide second messenger (GO:0007199 | 2.74939596 |
| 168 | plasma lipoprotein particle clearance (GO:0034381) | 2.74881072 |
| 169 | granulocyte activation (GO:0036230) | 2.74834654 |
| 170 | embryo implantation (GO:0007566) | 2.74738403 |
| 171 | early endosome to late endosome transport (GO:0045022) | 2.73824944 |
| 172 | phagocytosis, engulfment (GO:0006911) | 2.73518704 |
| 173 | extracellular fibril organization (GO:0043206) | 2.72479646 |
| 174 | negative regulation of smooth muscle contraction (GO:0045986) | 2.72275075 |
| 175 | cardiac cell development (GO:0055006) | 2.72005845 |
| 176 | regulation of germinal center formation (GO:0002634) | 2.71498867 |
| 177 | metanephric nephron epithelium development (GO:0072243) | 2.70712975 |
| 178 | renal filtration (GO:0097205) | 2.70658288 |
| 179 | positive regulation of response to biotic stimulus (GO:0002833) | 2.70643438 |
| 180 | oligosaccharide catabolic process (GO:0009313) | 2.70341729 |
| 181 | cell volume homeostasis (GO:0006884) | 2.70277010 |
| 182 | regulation of regulated secretory pathway (GO:1903305) | 2.69404689 |
| 183 | glycogen catabolic process (GO:0005980) | 2.68501267 |
| 184 | microglial cell activation (GO:0001774) | 2.67768897 |
| 185 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.66422586 |
| 186 | response to interferon-gamma (GO:0034341) | 2.65418621 |
| 187 | translational termination (GO:0006415) | 2.65059322 |
| 188 | regulation of lipopolysaccharide-mediated signaling pathway (GO:0031664) | 2.64780646 |
| 189 | positive regulation of interleukin-17 production (GO:0032740) | 2.62248874 |
| 190 | negative regulation of heart rate (GO:0010459) | 2.61787489 |
| 191 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.60431338 |
| 192 | glutathione derivative biosynthetic process (GO:1901687) | 2.59766273 |
| 193 | glutathione derivative metabolic process (GO:1901685) | 2.59766273 |
| 194 | protein retention in ER lumen (GO:0006621) | 2.59275574 |
| 195 | positive regulation of acute inflammatory response (GO:0002675) | 2.58471933 |
| 196 | purinergic nucleotide receptor signaling pathway (GO:0035590) | 2.56963410 |
| 197 | * one-carbon compound transport (GO:0019755) | 2.56607139 |
| 198 | renal system development (GO:0072001) | 2.54489114 |
| 199 | galactose metabolic process (GO:0006012) | 2.54172629 |
| 200 | hypotonic response (GO:0006971) | 10.5517451 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 5.86857601 |
| 2 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 5.69885411 |
| 3 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 4.71180113 |
| 4 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.53057334 |
| 5 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 4.23062076 |
| 6 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 3.76047230 |
| 7 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 3.51336740 |
| 8 | CLOCK_20551151_ChIP-Seq_293T_Human | 3.46497582 |
| 9 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.27130805 |
| 10 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 2.65928569 |
| 11 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.53883485 |
| 12 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 2.52210081 |
| 13 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.51074088 |
| 14 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 2.49287232 |
| 15 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.38757937 |
| 16 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.30288849 |
| 17 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 2.23553217 |
| 18 | RACK7_27058665_Chip-Seq_MCF-7_Human | 2.22356334 |
| 19 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.20206208 |
| 20 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.14977305 |
| 21 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.12174099 |
| 22 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.09379721 |
| 23 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.04771880 |
| 24 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 2.00069513 |
| 25 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.99743598 |
| 26 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.99742450 |
| 27 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.94057865 |
| 28 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.91008576 |
| 29 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.90904932 |
| 30 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.88476989 |
| 31 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.84555008 |
| 32 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.83982828 |
| 33 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.74089799 |
| 34 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.70341968 |
| 35 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.69905756 |
| 36 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.68708263 |
| 37 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.68596239 |
| 38 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.66182461 |
| 39 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.66120651 |
| 40 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.63770321 |
| 41 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.59858932 |
| 42 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.58579830 |
| 43 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.56944845 |
| 44 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.54785495 |
| 45 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.54450071 |
| 46 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.54108353 |
| 47 | SPI1_23127762_ChIP-Seq_K562_Human | 1.53893473 |
| 48 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.53529610 |
| 49 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.51715580 |
| 50 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.50975006 |
| 51 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.50235978 |
| 52 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.49781711 |
| 53 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.49429164 |
| 54 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.49239634 |
| 55 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 1.46219484 |
| 56 | SPI1_20517297_ChIP-Seq_HL60_Human | 1.46055799 |
| 57 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.45999905 |
| 58 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.43918548 |
| 59 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.43240742 |
| 60 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.42157960 |
| 61 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.41901119 |
| 62 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.41842965 |
| 63 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.40690367 |
| 64 | TP63_22573176_ChIP-Seq_HFKS_Human | 1.40615897 |
| 65 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.40074163 |
| 66 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.38578721 |
| 67 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 1.34841612 |
| 68 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.34733132 |
| 69 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.33450785 |
| 70 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.31948531 |
| 71 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.31867924 |
| 72 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.31205208 |
| 73 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 1.31083487 |
| 74 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.30732647 |
| 75 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.29853180 |
| 76 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.29728972 |
| 77 | CEBPB_22108803_ChIP-Seq_LS180_Human | 1.27902450 |
| 78 | MYB_26560356_Chip-Seq_TH2_Human | 1.27384105 |
| 79 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.27072906 |
| 80 | EOMES_21245162_ChIP-Seq_HESCs_Human | 1.26585292 |
| 81 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.26179640 |
| 82 | CTCF_20526341_ChIP-Seq_ESCs_Human | 1.24333849 |
| 83 | * CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.24277251 |
| 84 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.23743732 |
| 85 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.21501792 |
| 86 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.20490454 |
| 87 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.20311375 |
| 88 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 1.20143457 |
| 89 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.19515444 |
| 90 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.19333296 |
| 91 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.19246189 |
| 92 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.18921867 |
| 93 | CSB_26484114_Chip-Seq_FIBROBLAST_Human | 1.18795730 |
| 94 | ATF3_27146783_Chip-Seq_COLON_Human | 1.18755041 |
| 95 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.17936958 |
| 96 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.17733461 |
| 97 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.17690018 |
| 98 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.17611201 |
| 99 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.16893089 |
| 100 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.16627558 |
| 101 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.16127608 |
| 102 | TAF2_19829295_ChIP-Seq_ESCs_Human | 1.15463960 |
| 103 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 1.15346876 |
| 104 | GATA3_26560356_Chip-Seq_TH2_Human | 1.14863181 |
| 105 | FOXH1_21741376_ChIP-Seq_ESCs_Human | 1.13795094 |
| 106 | TDRD3_21172665_ChIP-Seq_MCF-7_Human | 1.13042347 |
| 107 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 1.12923273 |
| 108 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.12508228 |
| 109 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.12501250 |
| 110 | SA1_27219007_Chip-Seq_Bcells_Human | 1.12329880 |
| 111 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.11627891 |
| 112 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.10807321 |
| 113 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.10806330 |
| 114 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.10289181 |
| 115 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.10231237 |
| 116 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.09968166 |
| 117 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.09910356 |
| 118 | P300_27268052_Chip-Seq_Bcells_Human | 1.09661537 |
| 119 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.08486238 |
| 120 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.08315381 |
| 121 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.07722295 |
| 122 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.07473797 |
| 123 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.06547302 |
| 124 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.06406231 |
| 125 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.05864224 |
| 126 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 1.05624953 |
| 127 | MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 1.03920897 |
| 128 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 1.03661408 |
| 129 | EOMES_20176728_ChIP-ChIP_TSCs_Mouse | 1.03559305 |
| 130 | CTCF_21964334_Chip-Seq_Bcells_Human | 1.03286353 |
| 131 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 1.03122643 |
| 132 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.01911285 |
| 133 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.01738674 |
| 134 | NCOR_22424771_ChIP-Seq_293T_Human | 1.00798929 |
| 135 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.99958451 |
| 136 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.99899175 |
| 137 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.99899175 |
| 138 | KDM2B_26808549_Chip-Seq_K562_Human | 0.99845240 |
| 139 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 0.99617127 |
| 140 | SETDB1_19884255_ChIP-Seq_MESCs_Mouse | 0.98736728 |
| 141 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 0.98590453 |
| 142 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.98287379 |
| 143 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.98245345 |
| 144 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 0.97809356 |
| 145 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.97786916 |
| 146 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.97613491 |
| 147 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.97192142 |
| 148 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 0.96923128 |
| 149 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.96663842 |
| 150 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.96538119 |
| 151 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.96435225 |
| 152 | GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 0.95816792 |
| 153 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 0.94867695 |
| 154 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.94732079 |
| 155 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.94483288 |
| 156 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.94189719 |
| 157 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.93560871 |
| 158 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 0.93456096 |
| 159 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.93286285 |
| 160 | RUNX_20019798_ChIP-Seq_JUKART_Human | 0.92847713 |
| 161 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.92058079 |
| 162 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.92034787 |
| 163 | * SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.91934103 |
| 164 | CJUN_26792858_Chip-Seq_BT549_Human | 0.91395132 |
| 165 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.91239001 |
| 166 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 0.90335896 |
| 167 | P63_20808887_ChIP-Seq_KERATINOCYTES_Human | 0.89930281 |
| 168 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.87743388 |
| 169 | CEBPB_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.86654976 |
| 170 | NANOG_20526341_ChIP-Seq_ESCs_Human | 0.85526207 |
| 171 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 0.85347864 |
| 172 | MYB_26560356_Chip-Seq_TH1_Human | 0.84152848 |
| 173 | RAC3_21632823_ChIP-Seq_H3396_Human | 0.83886670 |
| 174 | MAF_26560356_Chip-Seq_TH1_Human | 0.83642698 |
| 175 | FOXH1_21741376_ChIP-Seq_EPCs_Human | 0.83617615 |
| 176 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.83282611 |
| 177 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.81096866 |
| 178 | VDR_21846776_ChIP-Seq_THP-1_Human | 0.78959770 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * MP0000516_abnormal_urinary_system | 7.81059828 |
| 2 | * MP0005367_renal/urinary_system_phenotyp | 7.81059828 |
| 3 | MP0001835_abnormal_antigen_presentation | 4.38451777 |
| 4 | MP0003646_muscle_fatigue | 3.73197461 |
| 5 | * MP0000534_abnormal_ureter_morphology | 3.50879319 |
| 6 | * MP0001756_abnormal_urination | 3.28157832 |
| 7 | MP0000013_abnormal_adipose_tissue | 2.93951081 |
| 8 | MP0003806_abnormal_nucleotide_metabolis | 2.91251281 |
| 9 | MP0002837_dystrophic_cardiac_calcinosis | 2.90305307 |
| 10 | MP0009379_abnormal_foot_pigmentation | 2.38870390 |
| 11 | MP0000462_abnormal_digestive_system | 2.34678038 |
| 12 | MP0005451_abnormal_body_composition | 2.33801947 |
| 13 | MP0006036_abnormal_mitochondrial_physio | 2.31507954 |
| 14 | MP0001958_emphysema | 2.30604090 |
| 15 | MP0001664_abnormal_digestion | 2.25331926 |
| 16 | MP0005671_abnormal_response_to | 2.23807539 |
| 17 | MP0006082_CNS_inflammation | 2.20074531 |
| 18 | MP0006054_spinal_hemorrhage | 2.12242443 |
| 19 | MP0005670_abnormal_white_adipose | 2.03318750 |
| 20 | MP0003724_increased_susceptibility_to | 2.00257163 |
| 21 | MP0010386_abnormal_urinary_bladder | 12.5299690 |
| 22 | MP0009785_altered_susceptibility_to | 1.98914874 |
| 23 | MP0002139_abnormal_hepatobiliary_system | 1.98586267 |
| 24 | MP0002148_abnormal_hypersensitivity_rea | 1.97752818 |
| 25 | MP0005058_abnormal_lysosome_morphology | 1.96277838 |
| 26 | MP0005464_abnormal_platelet_physiology | 1.93826466 |
| 27 | MP0005084_abnormal_gallbladder_morpholo | 1.93233789 |
| 28 | MP0001800_abnormal_humoral_immune | 1.84217385 |
| 29 | MP0009764_decreased_sensitivity_to | 1.83665335 |
| 30 | MP0000538_abnormal_urinary_bladder | 1.83336303 |
| 31 | MP0010329_abnormal_lipoprotein_level | 1.76466095 |
| 32 | MP0002166_altered_tumor_susceptibility | 1.75788752 |
| 33 | MP0002419_abnormal_innate_immunity | 1.72878695 |
| 34 | MP0000685_abnormal_immune_system | 1.68737006 |
| 35 | MP0008438_abnormal_cutaneous_collagen | 1.65172563 |
| 36 | MP0003436_decreased_susceptibility_to | 1.62276624 |
| 37 | MP0005025_abnormal_response_to | 1.61925124 |
| 38 | MP0000230_abnormal_systemic_arterial | 1.61384433 |
| 39 | MP0003303_peritoneal_inflammation | 1.60273433 |
| 40 | MP0001666_abnormal_nutrient_absorption | 1.58821440 |
| 41 | MP0004036_abnormal_muscle_relaxation | 1.57657487 |
| 42 | MP0005275_abnormal_skin_tensile | 1.56324098 |
| 43 | MP0005000_abnormal_immune_tolerance | 1.55079675 |
| 44 | MP0005085_abnormal_gallbladder_physiolo | 1.53876957 |
| 45 | MP0002452_abnormal_antigen_presenting | 1.52189819 |
| 46 | MP0003075_altered_response_to | 1.51227680 |
| 47 | MP0003252_abnormal_bile_duct | 1.46961607 |
| 48 | MP0008469_abnormal_protein_level | 1.44555449 |
| 49 | MP0002723_abnormal_immune_serum | 1.40622456 |
| 50 | MP0003191_abnormal_cellular_cholesterol | 1.38364602 |
| 51 | MP0005636_abnormal_mineral_homeostasis | 1.37762699 |
| 52 | MP0005330_cardiomyopathy | 1.37678797 |
| 53 | MP0002876_abnormal_thyroid_physiology | 1.33459318 |
| 54 | MP0000537_abnormal_urethra_morphology | 1.32613359 |
| 55 | MP0002106_abnormal_muscle_physiology | 1.30848906 |
| 56 | MP0003283_abnormal_digestive_organ | 1.29714837 |
| 57 | MP0001853_heart_inflammation | 1.29526350 |
| 58 | MP0005620_abnormal_muscle_contractility | 1.29061938 |
| 59 | MP0003172_abnormal_lysosome_physiology | 1.26052772 |
| 60 | MP0004233_abnormal_muscle_weight | 1.22220455 |
| 61 | MP0001790_abnormal_immune_system | 1.21476352 |
| 62 | MP0005387_immune_system_phenotype | 1.21476352 |
| 63 | MP0004272_abnormal_basement_membrane | 1.19620124 |
| 64 | MP0001873_stomach_inflammation | 1.17481616 |
| 65 | MP0002332_abnormal_exercise_endurance | 1.17164347 |
| 66 | MP0001819_abnormal_immune_cell | 1.16750288 |
| 67 | MP0005075_abnormal_melanosome_morpholog | 1.15471516 |
| 68 | MP0005408_hypopigmentation | 1.15292459 |
| 69 | MP0010155_abnormal_intestine_physiology | 1.15180479 |
| 70 | MP0005083_abnormal_biliary_tract | 1.14906670 |
| 71 | MP0002420_abnormal_adaptive_immunity | 1.14395398 |
| 72 | MP0000003_abnormal_adipose_tissue | 1.13993918 |
| 73 | MP0004185_abnormal_adipocyte_glucose | 1.12213613 |
| 74 | MP0005503_abnormal_tendon_morphology | 1.12167435 |
| 75 | MP0009333_abnormal_splenocyte_physiolog | 1.08102044 |
| 76 | MP0003566_abnormal_cell_adhesion | 1.07949528 |
| 77 | MP0002234_abnormal_pharynx_morphology | 1.07452461 |
| 78 | MP0002118_abnormal_lipid_homeostasis | 1.06368150 |
| 79 | MP0008875_abnormal_xenobiotic_pharmacok | 1.05454601 |
| 80 | MP0000858_altered_metastatic_potential | 1.05231018 |
| 81 | MP0005595_abnormal_vascular_smooth | 1.04967019 |
| 82 | * MP0009643_abnormal_urine_homeostasis | 1.04844995 |
| 83 | MP0000749_muscle_degeneration | 1.04186367 |
| 84 | MP0000751_myopathy | 1.04143459 |
| 85 | MP0005369_muscle_phenotype | 1.03504055 |
| 86 | MP0001845_abnormal_inflammatory_respons | 0.99395755 |
| 87 | MP0000750_abnormal_muscle_regeneration | 0.96966594 |
| 88 | MP0003011_delayed_dark_adaptation | 0.96880550 |
| 89 | MP0004084_abnormal_cardiac_muscle | 0.94895025 |
| 90 | MP0002006_tumorigenesis | 0.92925259 |
| 91 | MP0002909_abnormal_adrenal_gland | 0.90808608 |
| 92 | MP0001270_distended_abdomen | 0.89231896 |
| 93 | MP0003866_abnormal_defecation | 0.89038305 |
| 94 | MP0003638_abnormal_response/metabolism_ | 0.88460268 |
| 95 | MP0004142_abnormal_muscle_tone | 0.88093189 |
| 96 | MP0009053_abnormal_anal_canal | 0.87939809 |
| 97 | MP0003315_abnormal_perineum_morphology | 0.86809338 |
| 98 | MP0008872_abnormal_physiological_respon | 0.85637642 |
| 99 | MP0003123_paternal_imprinting | 0.85016626 |
| 100 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.83580332 |
| 101 | MP0000759_abnormal_skeletal_muscle | 0.83562916 |
| 102 | MP0000716_abnormal_immune_system | 0.83399005 |
| 103 | MP0003950_abnormal_plasma_membrane | 0.82857086 |
| 104 | MP0005266_abnormal_metabolism | 0.81187609 |
| 105 | MP0004087_abnormal_muscle_fiber | 0.81162095 |
| 106 | * MP0009642_abnormal_blood_homeostasis | 0.81006258 |
| 107 | MP0002796_impaired_skin_barrier | 0.77291453 |
| 108 | MP0001533_abnormal_skeleton_physiology | 0.77290939 |
| 109 | MP0002269_muscular_atrophy | 0.76948829 |
| 110 | MP0002998_abnormal_bone_remodeling | 0.76822643 |
| 111 | MP0001905_abnormal_dopamine_level | 0.76514499 |
| 112 | MP0003195_calcinosis | 0.76173843 |
| 113 | MP0003385_abnormal_body_wall | 0.76163795 |
| 114 | MP0000609_abnormal_liver_physiology | 0.75641952 |
| 115 | MP0003942_abnormal_urinary_system | 0.75357257 |
| 116 | MP0003879_abnormal_hair_cell | 0.74177853 |
| 117 | MP0005187_abnormal_penis_morphology | 0.74086203 |
| 118 | MP0002254_reproductive_system_inflammat | 0.72327596 |
| 119 | * MP0002136_abnormal_kidney_physiology | 0.71651207 |
| 120 | MP0005623_abnormal_meninges_morphology | 0.71524161 |
| 121 | MP0000465_gastrointestinal_hemorrhage | 0.63460864 |
| 122 | MP0002249_abnormal_larynx_morphology | 0.63353296 |
| 123 | MP0005375_adipose_tissue_phenotype | 0.60732872 |
| 124 | MP0005381_digestive/alimentary_phenotyp | 0.60345963 |
| 125 | MP0002127_abnormal_cardiovascular_syste | 0.59568614 |
| 126 | MP0003705_abnormal_hypodermis_morpholog | 0.59254683 |
| 127 | MP0000613_abnormal_salivary_gland | 0.57836046 |
| 128 | * MP0002135_abnormal_kidney_morphology | 0.57276966 |
| 129 | MP0010234_abnormal_vibrissa_follicle | 0.56534504 |
| 130 | MP0003115_abnormal_respiratory_system | 0.56494985 |
| 131 | MP0001765_abnormal_ion_homeostasis | 0.54161703 |
| 132 | MP0004264_abnormal_extraembryonic_tissu | 0.53793982 |
| 133 | MP0005023_abnormal_wound_healing | 0.51476968 |
| 134 | MP0004858_abnormal_nervous_system | 0.50521115 |
| 135 | MP0004145_abnormal_muscle_electrophysio | 0.50268254 |
| 136 | MP0004885_abnormal_endolymph | 0.47856838 |
| 137 | MP0004043_abnormal_pH_regulation | 0.47256160 |
| 138 | MP0005166_decreased_susceptibility_to | 0.45592567 |
| 139 | MP0005164_abnormal_response_to | 0.45472064 |
| 140 | MP0005365_abnormal_bile_salt | 0.45443827 |
| 141 | MP0005319_abnormal_enzyme/_coenzyme | 0.44600043 |
| 142 | MP0004019_abnormal_vitamin_homeostasis | 0.43233578 |
| 143 | MP0003938_abnormal_ear_development | 0.42603284 |
| 144 | MP0000249_abnormal_blood_vessel | 0.42464369 |
| 145 | MP0001944_abnormal_pancreas_morphology | 0.42186526 |
| 146 | MP0002282_abnormal_trachea_morphology | 0.42075207 |
| 147 | MP0004130_abnormal_muscle_cell | 0.40765148 |
| 148 | MP0005220_abnormal_exocrine_pancreas | 0.39638194 |
| 149 | MP0005388_respiratory_system_phenotype | 0.38430095 |
| 150 | MP0002133_abnormal_respiratory_system | 0.38430095 |
| 151 | MP0003045_fibrosis | 0.37666926 |
| 152 | MP0010368_abnormal_lymphatic_system | 0.36925461 |
| 153 | MP0000747_muscle_weakness | 0.33784620 |
| 154 | MP0002092_abnormal_eye_morphology | 0.33538559 |
| 155 | MP0009840_abnormal_foam_cell | 0.32830163 |
| 156 | MP0000767_abnormal_smooth_muscle | 0.31899099 |
| 157 | MP0000163_abnormal_cartilage_morphology | 0.31864515 |
| 158 | MP0004134_abnormal_chest_morphology | 0.31033867 |
| 159 | MP0005508_abnormal_skeleton_morphology | 0.30860304 |
| 160 | MP0000428_abnormal_craniofacial_morphol | 0.30770292 |
| 161 | MP0002060_abnormal_skin_morphology | 0.29890811 |
| 162 | MP0001299_abnormal_eye_distance/ | 0.29456782 |
| 163 | MP0006138_congestive_heart_failure | 0.29241859 |
| 164 | MP0004484_altered_response_of | 0.28342922 |
| 165 | MP0002108_abnormal_muscle_morphology | 0.26425931 |
| 166 | * MP0005332_abnormal_amino_acid | 0.26066795 |
| 167 | MP0005360_urolithiasis | 0.25960424 |
| 168 | MP0004215_abnormal_myocardial_fiber | 0.25878936 |
| 169 | MP0000477_abnormal_intestine_morphology | 0.25714763 |
| 170 | MP0002896_abnormal_bone_mineralization | 0.25671907 |
| 171 | MP0003119_abnormal_digestive_system | 0.24870522 |
| 172 | MP0010030_abnormal_orbit_morphology | 0.24400473 |
| 173 | MP0002233_abnormal_nose_morphology | 0.24248385 |
| 174 | MP0002128_abnormal_blood_circulation | 0.24066038 |
| 175 | MP0001879_abnormal_lymphatic_vessel | 0.23266699 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Aortic dissection (HP:0002647) | 8.03248698 |
| 2 | Neoplasm of the heart (HP:0100544) | 7.22026579 |
| 3 | Gastrointestinal dysmotility (HP:0002579) | 6.99172274 |
| 4 | Malnutrition (HP:0004395) | 6.39970806 |
| 5 | Muscle fiber inclusion bodies (HP:0100299) | 5.90508973 |
| 6 | Nemaline bodies (HP:0003798) | 5.87108186 |
| 7 | Ankle contracture (HP:0006466) | 5.63236346 |
| 8 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 5.63181358 |
| 9 | Cerebral aneurysm (HP:0004944) | 5.43701291 |
| 10 | Hydroureter (HP:0000072) | 4.76707905 |
| 11 | Abdominal situs inversus (HP:0003363) | 4.66170828 |
| 12 | Abnormality of abdominal situs (HP:0011620) | 4.66170828 |
| 13 | Ulnar bowing (HP:0003031) | 4.49076577 |
| 14 | Wrist flexion contracture (HP:0001239) | 4.40018125 |
| 15 | Broad distal phalanx of finger (HP:0009836) | 4.35245529 |
| 16 | Exercise-induced myalgia (HP:0003738) | 4.25611349 |
| 17 | Aortic regurgitation (HP:0001659) | 4.22375479 |
| 18 | Stridor (HP:0010307) | 4.12830801 |
| 19 | Abnormal pupillary function (HP:0007686) | 4.08634852 |
| 20 | Long toe (HP:0010511) | 3.86227991 |
| 21 | Increased density of long bones (HP:0006392) | 3.81616033 |
| 22 | Broad face (HP:0000283) | 3.66126826 |
| 23 | Absent frontal sinuses (HP:0002688) | 3.62818519 |
| 24 | Chronic obstructive pulmonary disease (HP:0006510) | 3.61781902 |
| 25 | Obstructive lung disease (HP:0006536) | 3.61781902 |
| 26 | Hyperparathyroidism (HP:0000843) | 3.55876200 |
| 27 | Scapular winging (HP:0003691) | 3.53022014 |
| 28 | Selective tooth agenesis (HP:0001592) | 3.50499976 |
| 29 | Aplasia/Hypoplasia of the 4th metacarpal (HP:0010042) | 3.49424727 |
| 30 | Short 4th metacarpal (HP:0010044) | 3.49424727 |
| 31 | Mesomelia (HP:0003027) | 3.48065730 |
| 32 | Dilatation of the ascending aorta (HP:0005111) | 3.43649018 |
| 33 | Short hallux (HP:0010109) | 3.41237204 |
| 34 | Eczematoid dermatitis (HP:0000976) | 3.36680567 |
| 35 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 3.36061124 |
| 36 | Osteolytic defects of the hand bones (HP:0009699) | 3.36061124 |
| 37 | Aneurysm (HP:0002617) | 3.35978839 |
| 38 | Exercise-induced muscle cramps (HP:0003710) | 3.30242000 |
| 39 | Radial bowing (HP:0002986) | 3.26882253 |
| 40 | Hepatocellular necrosis (HP:0001404) | 3.23988559 |
| 41 | Abnormality of the calcaneus (HP:0008364) | 3.23317272 |
| 42 | Abnormal foot bone ossification (HP:0010675) | 3.23290814 |
| 43 | Bicuspid aortic valve (HP:0001647) | 3.20252680 |
| 44 | Muscle hypertrophy of the lower extremities (HP:0008968) | 3.18884406 |
| 45 | Distal arthrogryposis (HP:0005684) | 3.17845991 |
| 46 | Spastic diplegia (HP:0001264) | 3.17580304 |
| 47 | Aplasia/Hypoplasia of the hallux (HP:0008362) | 3.15255448 |
| 48 | Acute necrotizing encephalopathy (HP:0006965) | 3.14941182 |
| 49 | Amyloidosis (HP:0011034) | 3.13147401 |
| 50 | Rhabdomyolysis (HP:0003201) | 3.12305383 |
| 51 | Persistence of primary teeth (HP:0006335) | 3.11074829 |
| 52 | Long foot (HP:0001833) | 3.03866265 |
| 53 | Hemorrhage of the eye (HP:0011885) | 3.02300906 |
| 54 | Deep venous thrombosis (HP:0002625) | 3.01818909 |
| 55 | Myopathic facies (HP:0002058) | 3.01039208 |
| 56 | Hepatic necrosis (HP:0002605) | 3.00861900 |
| 57 | Asymmetric septal hypertrophy (HP:0001670) | 2.99737617 |
| 58 | Gingival bleeding (HP:0000225) | 2.98262643 |
| 59 | Facial diplegia (HP:0001349) | 2.95038265 |
| 60 | Gastrointestinal infarctions (HP:0005244) | 2.93616211 |
| 61 | Abnormality of macrophages (HP:0004311) | 2.93360619 |
| 62 | Abnormality of the 2nd finger (HP:0004100) | 2.90497861 |
| 63 | Congenital, generalized hypertrichosis (HP:0004540) | 2.90082484 |
| 64 | Round ear (HP:0100830) | 2.88935887 |
| 65 | Mitochondrial inheritance (HP:0001427) | 2.83184952 |
| 66 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.81052949 |
| 67 | Aplasia/Hypoplasia of the frontal sinuses (HP:0009119) | 2.80936552 |
| 68 | Acute encephalopathy (HP:0006846) | 2.79993824 |
| 69 | Muscle fiber splitting (HP:0003555) | 2.72586470 |
| 70 | Calf muscle hypertrophy (HP:0008981) | 2.71041076 |
| 71 | Fused cervical vertebrae (HP:0002949) | 2.70040132 |
| 72 | Myoglobinuria (HP:0002913) | 2.69556398 |
| 73 | Cerebral palsy (HP:0100021) | 2.67993086 |
| 74 | Bowed forearm bones (HP:0003956) | 2.67068331 |
| 75 | Bowing of the arm (HP:0006488) | 2.67068331 |
| 76 | Joint hemorrhage (HP:0005261) | 2.63650752 |
| 77 | Abnormality of the right ventricle (HP:0001707) | 2.61226673 |
| 78 | Chest pain (HP:0100749) | 2.60818933 |
| 79 | Abnormality of oral frenula (HP:0000190) | 2.60045539 |
| 80 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.60027065 |
| 81 | Progressive macrocephaly (HP:0004481) | 2.59568908 |
| 82 | Type 1 muscle fiber predominance (HP:0003803) | 2.58038251 |
| 83 | Elbow flexion contracture (HP:0002987) | 2.57340482 |
| 84 | Camptodactyly of toe (HP:0001836) | 2.56125125 |
| 85 | Petechiae (HP:0000967) | 2.54101663 |
| 86 | Spontaneous abortion (HP:0005268) | 2.52415944 |
| 87 | Intestinal malrotation (HP:0002566) | 2.49039109 |
| 88 | Knee flexion contracture (HP:0006380) | 2.48435347 |
| 89 | Hypobetalipoproteinemia (HP:0003563) | 2.47045989 |
| 90 | Subaortic stenosis (HP:0001682) | 2.46678954 |
| 91 | Abnormality of the left ventricular outflow tract (HP:0011103) | 2.46678954 |
| 92 | EMG: myopathic abnormalities (HP:0003458) | 2.45320271 |
| 93 | Gangrene (HP:0100758) | 2.45035763 |
| 94 | Tarsal synostosis (HP:0008368) | 2.44832128 |
| 95 | Ureteral stenosis (HP:0000071) | 2.44363640 |
| 96 | Muscle stiffness (HP:0003552) | 2.43760131 |
| 97 | Abnormality of the 4th metacarpal (HP:0010012) | 2.43119582 |
| 98 | Abnormality of the axillary hair (HP:0100134) | 2.41916737 |
| 99 | Abnormality of secondary sexual hair (HP:0009888) | 2.41916737 |
| 100 | Abnormal ossification of hand bones (HP:0005921) | 2.41661886 |
| 101 | Vacuolated lymphocytes (HP:0001922) | 2.37969816 |
| 102 | Abnormality of the common coagulation pathway (HP:0010990) | 2.37676277 |
| 103 | Hemoptysis (HP:0002105) | 2.37422689 |
| 104 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.36729577 |
| 105 | Recurrent cutaneous fungal infections (HP:0011370) | 2.36729577 |
| 106 | Epistaxis (HP:0000421) | 2.35922319 |
| 107 | Abnormality of the pleura (HP:0002103) | 2.34761823 |
| 108 | Stroke (HP:0001297) | 2.33972607 |
| 109 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.33415093 |
| 110 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.33415093 |
| 111 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.33111947 |
| 112 | Tachypnea (HP:0002789) | 2.30391624 |
| 113 | Recurrent abscess formation (HP:0002722) | 2.29424307 |
| 114 | Increased mean platelet volume (HP:0011877) | 2.28882936 |
| 115 | Increased CSF lactate (HP:0002490) | 2.28841467 |
| 116 | Vasculitis (HP:0002633) | 2.25965568 |
| 117 | Meningitis (HP:0001287) | 2.22737238 |
| 118 | Ulnar deviation of the wrist (HP:0003049) | 2.20571637 |
| 119 | Ureteral obstruction (HP:0006000) | 2.19715789 |
| 120 | 3-Methylglutaconic aciduria (HP:0003535) | 2.19400251 |
| 121 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.18897236 |
| 122 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.18693108 |
| 123 | Synostosis involving bones of the lower limbs (HP:0009138) | 2.17761681 |
| 124 | Synostosis involving bones of the feet (HP:0009140) | 2.17761681 |
| 125 | Distal lower limb muscle weakness (HP:0009053) | 2.17683953 |
| 126 | Glossoptosis (HP:0000162) | 2.16481155 |
| 127 | Recurrent bacterial skin infections (HP:0005406) | 2.16186728 |
| 128 | Fatigue (HP:0012378) | 2.15738346 |
| 129 | Dysostosis multiplex (HP:0000943) | 2.15556017 |
| 130 | Testicular atrophy (HP:0000029) | 2.14998655 |
| 131 | Abnormality of the shoulder girdle musculature (HP:0001435) | 2.14928244 |
| 132 | Exertional dyspnea (HP:0002875) | 2.13348768 |
| 133 | Aplasia/Hypoplasia involving the sinuses (HP:0009120) | 2.12184984 |
| 134 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.12053638 |
| 135 | Purpura (HP:0000979) | 2.10698529 |
| 136 | Thrombophlebitis (HP:0004418) | 2.10321792 |
| 137 | Systemic lupus erythematosus (HP:0002725) | 2.10024351 |
| 138 | Fibular hypoplasia (HP:0003038) | 2.07124024 |
| 139 | Urticaria (HP:0001025) | 2.05941439 |
| 140 | Polyneuropathy (HP:0001271) | 2.05542060 |
| 141 | Abnormality of the frontal sinuses (HP:0002687) | 2.05133884 |
| 142 | Recurrent fungal infections (HP:0002841) | 2.04562428 |
| 143 | Increased serum ferritin (HP:0003281) | 2.02476036 |
| 144 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.00751689 |
| 145 | Synostosis of carpal bones (HP:0005048) | 2.00122257 |
| 146 | Neck muscle weakness (HP:0000467) | 2.00037586 |
| 147 | Aortic aneurysm (HP:0004942) | 10.7302629 |
| 148 | Carpal synostosis (HP:0009702) | 1.99961390 |
| 149 | Increased muscle lipid content (HP:0009058) | 1.99926231 |
| 150 | Leukodystrophy (HP:0002415) | 1.99721531 |
| 151 | Hypothermia (HP:0002045) | 1.99419902 |
| 152 | Increased intramyocellular lipid droplets (HP:0012240) | 1.98878796 |
| 153 | Recurrent skin infections (HP:0001581) | 1.96849749 |
| 154 | Complete atrioventricular canal defect (HP:0001674) | 1.95779379 |
| 155 | Arterial thrombosis (HP:0004420) | 1.94623019 |
| 156 | Cerebral edema (HP:0002181) | 1.92617341 |
| 157 | Increased cerebral lipofuscin (HP:0011813) | 1.92603290 |
| 158 | Hyporeflexia of lower limbs (HP:0002600) | 1.92418612 |
| 159 | Abnormal platelet volume (HP:0011876) | 1.90463293 |
| 160 | Delayed closure of the anterior fontanelle (HP:0001476) | 1.88219296 |
| 161 | Limb-girdle muscle atrophy (HP:0003797) | 1.87884623 |
| 162 | Prolonged partial thromboplastin time (HP:0003645) | 1.86697348 |
| 163 | Absent phalangeal crease (HP:0006109) | 1.86578045 |
| 164 | Arachnodactyly (HP:0001166) | 1.86206233 |
| 165 | Hyperglycinuria (HP:0003108) | 1.86182936 |
| 166 | Abnormality of the odontoid process (HP:0003310) | 1.85916130 |
| 167 | Mitral valve prolapse (HP:0001634) | 1.85298184 |
| 168 | Abnormality of the prostate (HP:0008775) | 1.85256066 |
| 169 | Pruritus (HP:0000989) | 1.84936461 |
| 170 | Wormian bones (HP:0002645) | 1.84768260 |
| 171 | Short chin (HP:0000331) | 1.84719607 |
| 172 | Short clavicles (HP:0000894) | 1.84428264 |
| 173 | Sudden death (HP:0001699) | 1.84262972 |
| 174 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 1.82374337 |
| 175 | Hydronephrosis (HP:0000126) | 1.82134174 |
| 176 | Skin rash (HP:0000988) | 1.80954994 |
| 177 | Abnormality of complement system (HP:0005339) | 1.80789126 |
| 178 | Abnormality of the distal phalanges of the toes (HP:0010182) | 1.80738440 |
| 179 | Atrioventricular block (HP:0001678) | 1.80577190 |
| 180 | Pulmonary infiltrates (HP:0002113) | 1.80554715 |
| 181 | Broad metatarsal (HP:0001783) | 1.80517316 |
| 182 | Malignant hyperthermia (HP:0002047) | 1.80113755 |
| 183 | Absent toe (HP:0010760) | 1.79901316 |
| 184 | Short humerus (HP:0005792) | 1.79537394 |
| 185 | Increased variability in muscle fiber diameter (HP:0003557) | 1.78901952 |
| 186 | Seborrheic dermatitis (HP:0001051) | 1.78631558 |
| 187 | Aplasia/hypoplasia of the humerus (HP:0006507) | 1.75100844 |
| 188 | Omphalocele (HP:0001539) | 1.71682212 |
| 189 | Joint contractures involving the joints of the feet (HP:0100492) | 1.70539230 |
| 190 | Flexion contracture of toe (HP:0005830) | 1.70539230 |
| 191 | Right ventricular cardiomyopathy (HP:0011663) | 1.70473918 |
| 192 | Aplasia/Hypoplasia of the clavicles (HP:0006710) | 1.66881506 |
| 193 | Cone-shaped epiphyses of the phalanges of the hand (HP:0010230) | 1.66794725 |
| 194 | Gout (HP:0001997) | 1.66123968 |
| 195 | Spinal rigidity (HP:0003306) | 1.63285020 |
| 196 | Abnormal umbilical cord blood vessels (HP:0011403) | 1.62957069 |
| 197 | Single umbilical artery (HP:0001195) | 1.62957069 |
| 198 | Abnormality of the fetal cardiovascular system (HP:0010948) | 1.62957069 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MYLK | 8.82641196 |
| 2 | CDK19 | 4.65829852 |
| 3 | BMPR2 | 4.46807923 |
| 4 | OBSCN | 4.24532389 |
| 5 | DMPK | 3.38948365 |
| 6 | PIK3CG | 2.89809409 |
| 7 | CSF1R | 2.68041532 |
| 8 | PAK2 | 2.65232709 |
| 9 | EPHA2 | 2.47335886 |
| 10 | RIPK4 | 2.33683426 |
| 11 | MST1R | 2.07123813 |
| 12 | TTN | 10.1331344 |
| 13 | MUSK | 1.95151691 |
| 14 | MAP4K1 | 1.89829132 |
| 15 | LMTK2 | 1.89367791 |
| 16 | MINK1 | 1.72339275 |
| 17 | KIT | 1.67111294 |
| 18 | TYK2 | 1.65154620 |
| 19 | TNK2 | 1.65024111 |
| 20 | NUAK1 | 1.65023551 |
| 21 | EPHB2 | 1.63415979 |
| 22 | DDR2 | 1.63355518 |
| 23 | BLK | 1.52285103 |
| 24 | CAMK2G | 1.51535843 |
| 25 | ILK | 1.46800404 |
| 26 | MATK | 1.44269673 |
| 27 | PAK1 | 1.42388919 |
| 28 | LYN | 1.35905766 |
| 29 | OXSR1 | 1.35793896 |
| 30 | FLT3 | 1.33048779 |
| 31 | MAP3K2 | 1.29316753 |
| 32 | DAPK3 | 1.27324880 |
| 33 | IKBKB | 1.22731947 |
| 34 | RPS6KA2 | 1.22710217 |
| 35 | DYRK1B | 1.22321118 |
| 36 | TRPM7 | 1.12615207 |
| 37 | CSK | 1.12502862 |
| 38 | RAF1 | 1.12312938 |
| 39 | SYK | 1.11676684 |
| 40 | TRIB3 | 1.11281030 |
| 41 | MAPKAPK3 | 1.10710127 |
| 42 | FGFR3 | 1.10233257 |
| 43 | WNK4 | 1.09564895 |
| 44 | CDC42BPA | 1.08473311 |
| 45 | PAK3 | 1.07292716 |
| 46 | MAPK12 | 1.02570890 |
| 47 | TAOK3 | 1.01741651 |
| 48 | ARAF | 1.00691877 |
| 49 | GRK6 | 1.00319333 |
| 50 | FES | 0.98999807 |
| 51 | BTK | 0.96932317 |
| 52 | PTK2 | 0.95879795 |
| 53 | RPS6KB2 | 0.94568750 |
| 54 | CAMK2B | 0.94086593 |
| 55 | MET | 0.93180111 |
| 56 | RIPK1 | 0.92025591 |
| 57 | ERBB3 | 0.89367777 |
| 58 | KSR2 | 0.86478209 |
| 59 | JAK1 | 0.85175532 |
| 60 | DAPK2 | 0.81406835 |
| 61 | PDK1 | 0.78573762 |
| 62 | FGR | 0.78218039 |
| 63 | KDR | 0.77364139 |
| 64 | EEF2K | 0.77294947 |
| 65 | GRK5 | 0.76304593 |
| 66 | NME2 | 0.75159385 |
| 67 | PDPK1 | 0.74136584 |
| 68 | BUB1 | 0.72880757 |
| 69 | CAMK2D | 0.72229888 |
| 70 | WNK3 | 0.71545165 |
| 71 | JAK3 | 0.71372292 |
| 72 | TESK1 | 0.70412098 |
| 73 | ZAP70 | 0.70336962 |
| 74 | AKT3 | 0.70245297 |
| 75 | LCK | 0.70104916 |
| 76 | DAPK1 | 0.69786326 |
| 77 | RPS6KC1 | 0.69134453 |
| 78 | RPS6KL1 | 0.69134453 |
| 79 | HCK | 0.68410626 |
| 80 | WNK1 | 0.64445482 |
| 81 | ROCK2 | 0.63170261 |
| 82 | TLK1 | 0.61437802 |
| 83 | PNCK | 0.61281694 |
| 84 | TEC | 0.61014866 |
| 85 | GSK3A | 0.60391564 |
| 86 | ROCK1 | 0.59709153 |
| 87 | PIK3CA | 0.59524713 |
| 88 | MAP3K3 | 0.56591530 |
| 89 | RPS6KA6 | 0.56521914 |
| 90 | MAP3K1 | 0.55731656 |
| 91 | BCKDK | 0.53734281 |
| 92 | TBK1 | 0.53129024 |
| 93 | MAP2K1 | 0.52980486 |
| 94 | ITK | 0.52601085 |
| 95 | GRK1 | 0.52412012 |
| 96 | LIMK1 | 0.51828994 |
| 97 | TAOK1 | 0.51660810 |
| 98 | JAK2 | 0.50778523 |
| 99 | PIM2 | 0.50685534 |
| 100 | TAOK2 | 0.50616563 |
| 101 | TSSK6 | 0.49219578 |
| 102 | IGF1R | 0.48461858 |
| 103 | MAP3K13 | 0.47487234 |
| 104 | MAP3K14 | 0.47275208 |
| 105 | GRK7 | 0.47129093 |
| 106 | FER | 0.46807531 |
| 107 | PHKG2 | 0.46750130 |
| 108 | PHKG1 | 0.46750130 |
| 109 | MAPKAPK2 | 0.46259746 |
| 110 | EPHB1 | 0.45798625 |
| 111 | PRKACB | 0.44282814 |
| 112 | CAMK1 | 0.43615795 |
| 113 | MARK3 | 0.43230834 |
| 114 | LRRK2 | 0.42040009 |
| 115 | PKN1 | 0.40359327 |
| 116 | SCYL2 | 0.40157524 |
| 117 | PRKAA2 | 0.39896314 |
| 118 | ERN1 | 0.39340407 |
| 119 | EGFR | 0.39274123 |
| 120 | PRKCI | 0.37936353 |
| 121 | SIK1 | 0.36666290 |
| 122 | STK24 | 0.35765695 |
| 123 | MAPK4 | 0.35339037 |
| 124 | PINK1 | 0.35034113 |
| 125 | PRKACG | 0.34489893 |
| 126 | TXK | 0.34363743 |
| 127 | INSRR | 0.33357528 |
| 128 | MAP4K2 | 0.32699619 |
| 129 | MOS | 0.30776913 |
| 130 | IRAK2 | 0.28882976 |
| 131 | IRAK4 | 0.28804714 |
| 132 | FYN | 0.27821147 |
| 133 | TGFBR2 | 0.26014654 |
| 134 | NTRK1 | 0.24909208 |
| 135 | PKN2 | 0.24134715 |
| 136 | LATS2 | 0.23771260 |
| 137 | PTK6 | 0.23634387 |
| 138 | PDGFRA | 0.22429079 |
| 139 | MAP2K3 | 0.21396822 |
| 140 | MAP2K4 | 0.21360047 |
| 141 | PAK4 | 0.18725704 |
| 142 | PDK4 | 0.17077707 |
| 143 | PDK3 | 0.17077707 |
| 144 | MTOR | 0.16118871 |
| 145 | MAP2K2 | 0.16104190 |
| 146 | TTK | 0.13887648 |
| 147 | PAK6 | 0.12659439 |
| 148 | WEE1 | 0.12612965 |
| 149 | NME1 | 0.11941223 |
| 150 | PTK2B | 0.11246593 |
| 151 | KSR1 | 0.10813512 |
| 152 | MAPKAPK5 | 0.09448339 |
| 153 | MAP3K12 | 0.09301318 |
| 154 | PRKCD | 0.07893184 |
| 155 | MAPK15 | 0.07731737 |
| 156 | STK38 | 0.07607397 |
| 157 | TIE1 | 0.07523060 |
| 158 | ALK | 0.07243115 |
| 159 | TYRO3 | 0.07009257 |
| 160 | RPS6KA1 | 0.06804311 |
| 161 | SRC | 0.06360404 |
| 162 | MAP2K6 | 0.06239348 |
| 163 | FGFR4 | 0.05533646 |
| 164 | PRKG1 | 0.05173194 |
| 165 | EPHA3 | 0.04735079 |
| 166 | CSNK1A1L | 0.04190779 |
| 167 | PRKCE | 0.03172878 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Asthma_Homo sapiens_hsa05310 | 6.38186676 |
| 2 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 5.30474889 |
| 3 | Allograft rejection_Homo sapiens_hsa05330 | 4.37999601 |
| 4 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 4.22554275 |
| 5 | Graft-versus-host disease_Homo sapiens_hsa05332 | 4.13453268 |
| 6 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 3.72898997 |
| 7 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 3.62562502 |
| 8 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 3.57100156 |
| 9 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 3.31611511 |
| 10 | Viral myocarditis_Homo sapiens_hsa05416 | 2.73377375 |
| 11 | Leishmaniasis_Homo sapiens_hsa05140 | 2.67660862 |
| 12 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.57073060 |
| 13 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.33618630 |
| 14 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 2.33594384 |
| 15 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 2.28631003 |
| 16 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.25048114 |
| 17 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 2.20622660 |
| 18 | Focal adhesion_Homo sapiens_hsa04510 | 2.12888879 |
| 19 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 2.07956497 |
| 20 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.98641852 |
| 21 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.93881720 |
| 22 | Tight junction_Homo sapiens_hsa04530 | 1.87373654 |
| 23 | Circadian rhythm_Homo sapiens_hsa04710 | 1.80427986 |
| 24 | Parkinsons disease_Homo sapiens_hsa05012 | 1.78331035 |
| 25 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.77327711 |
| 26 | Platelet activation_Homo sapiens_hsa04611 | 1.75077920 |
| 27 | Histidine metabolism_Homo sapiens_hsa00340 | 1.73175143 |
| 28 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.71511760 |
| 29 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.63559741 |
| 30 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.59439406 |
| 31 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.54090582 |
| 32 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 1.53877888 |
| 33 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.51180666 |
| 34 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.50086507 |
| 35 | * Bladder cancer_Homo sapiens_hsa05219 | 1.49095317 |
| 36 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.46264715 |
| 37 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 1.43800212 |
| 38 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.43631600 |
| 39 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.42542282 |
| 40 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.42505064 |
| 41 | Tuberculosis_Homo sapiens_hsa05152 | 1.41985718 |
| 42 | Alzheimers disease_Homo sapiens_hsa05010 | 1.38809914 |
| 43 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.35021420 |
| 44 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.34802017 |
| 45 | Prion diseases_Homo sapiens_hsa05020 | 1.30489373 |
| 46 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.27248243 |
| 47 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.25243848 |
| 48 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.24870915 |
| 49 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.22728871 |
| 50 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.16908131 |
| 51 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.11909450 |
| 52 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.08333332 |
| 53 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.06585303 |
| 54 | Insulin secretion_Homo sapiens_hsa04911 | 1.05253258 |
| 55 | Amoebiasis_Homo sapiens_hsa05146 | 1.05009281 |
| 56 | Other glycan degradation_Homo sapiens_hsa00511 | 1.04103833 |
| 57 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.03378303 |
| 58 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.00298906 |
| 59 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.99086338 |
| 60 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.98974367 |
| 61 | Influenza A_Homo sapiens_hsa05164 | 0.98267555 |
| 62 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.98056529 |
| 63 | Proteasome_Homo sapiens_hsa03050 | 0.95550512 |
| 64 | Huntingtons disease_Homo sapiens_hsa05016 | 0.95265666 |
| 65 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.95144549 |
| 66 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.91874451 |
| 67 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.91761799 |
| 68 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.90257502 |
| 69 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.88204082 |
| 70 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.87659803 |
| 71 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.86609868 |
| 72 | Phagosome_Homo sapiens_hsa04145 | 0.85123675 |
| 73 | Lysosome_Homo sapiens_hsa04142 | 0.85025596 |
| 74 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.84472704 |
| 75 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.83749752 |
| 76 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.82734123 |
| 77 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.81890805 |
| 78 | Ribosome_Homo sapiens_hsa03010 | 0.81523812 |
| 79 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.80626341 |
| 80 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.80448918 |
| 81 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.80365695 |
| 82 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.80156901 |
| 83 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.79992429 |
| 84 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.77055259 |
| 85 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.76821874 |
| 86 | Long-term potentiation_Homo sapiens_hsa04720 | 0.75960968 |
| 87 | Legionellosis_Homo sapiens_hsa05134 | 0.75753911 |
| 88 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.75515410 |
| 89 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.74136426 |
| 90 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.73967254 |
| 91 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.71543097 |
| 92 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.71417214 |
| 93 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.71185771 |
| 94 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.70903306 |
| 95 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.70407427 |
| 96 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.70119088 |
| 97 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.69730400 |
| 98 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.68778873 |
| 99 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.68591259 |
| 100 | Melanogenesis_Homo sapiens_hsa04916 | 0.67979490 |
| 101 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.67099612 |
| 102 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.66918226 |
| 103 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.66340875 |
| 104 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.65980097 |
| 105 | Bile secretion_Homo sapiens_hsa04976 | 0.64457842 |
| 106 | Insulin resistance_Homo sapiens_hsa04931 | 0.64039269 |
| 107 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.62903977 |
| 108 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.62752394 |
| 109 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.62613658 |
| 110 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.61469668 |
| 111 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.61296999 |
| 112 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.59581387 |
| 113 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.57310848 |
| 114 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.56370151 |
| 115 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.55910581 |
| 116 | Cocaine addiction_Homo sapiens_hsa05030 | 0.55605749 |
| 117 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.54286301 |
| 118 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.54182736 |
| 119 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.52820072 |
| 120 | Thyroid cancer_Homo sapiens_hsa05216 | 0.52765683 |
| 121 | Gap junction_Homo sapiens_hsa04540 | 0.52316987 |
| 122 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.51408833 |
| 123 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.51155801 |
| 124 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.49675977 |
| 125 | Salmonella infection_Homo sapiens_hsa05132 | 0.47956632 |
| 126 | Galactose metabolism_Homo sapiens_hsa00052 | 0.47502114 |
| 127 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.46781407 |
| 128 | Pertussis_Homo sapiens_hsa05133 | 0.46574706 |
| 129 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.45283262 |
| 130 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.44482528 |
| 131 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.44249995 |
| 132 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.43449831 |
| 133 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.43057368 |
| 134 | GABAergic synapse_Homo sapiens_hsa04727 | 0.42423427 |
| 135 | Shigellosis_Homo sapiens_hsa05131 | 0.42080935 |
| 136 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.41813494 |
| 137 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.40078429 |
| 138 | Circadian entrainment_Homo sapiens_hsa04713 | 0.39859055 |
| 139 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.39776452 |
| 140 | Adherens junction_Homo sapiens_hsa04520 | 0.39111894 |
| 141 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.38837193 |
| 142 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.37867737 |
| 143 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.37770650 |
| 144 | Protein export_Homo sapiens_hsa03060 | 0.37007473 |
| 145 | Carbon metabolism_Homo sapiens_hsa01200 | 0.34855675 |
| 146 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.34218539 |
| 147 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.33337360 |
| 148 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.33210904 |
| 149 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.32001973 |
| 150 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.31728645 |
| 151 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.30934834 |
| 152 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.30485428 |
| 153 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.30086961 |
| 154 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.25176111 |
| 155 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.25082081 |
| 156 | Retinol metabolism_Homo sapiens_hsa00830 | 0.24316636 |
| 157 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.22035746 |
| 158 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.21190991 |
| 159 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.20577948 |
| 160 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.16574110 |
| 161 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.15570083 |
| 162 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.11704159 |
| 163 | Metabolic pathways_Homo sapiens_hsa01100 | 0.11320995 |
| 164 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.10365023 |
| 165 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.08658648 |

